The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation

  • Mol Oncol. 2024 Mar 27. doi: 10.1002/1878-0261.13645.
Petra Marttila  1 Nadilly Bonagas  1 Christina Chalkiadaki  1 Hannah Stigsdotter  1 Korbinian Schelzig  1 Jianyu Shen  1 Crystal M Farhat  1 Amber Hondema  1 Julian Albers  1 Elisée Wiita  1 Azita Rasti  1 Ulrika Warpman Berglund  1 Ana Slipicevic  1  2 Oliver Mortusewicz  1 Thomas Helleday  1  3
Affiliations
  • 1. Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
  • 2. One-carbon Therapeutics AB, Stockholm, Sweden.
  • 3. Weston Park Cancer Centre, Department of Oncology and Metabolism, The Medical School, University of Sheffield, UK.
Abstract

The one-carbon metabolism enzyme bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2 (MTHFD2) is among the most overexpressed proteins across tumors and is widely recognized as a promising Anticancer target. While MTHFD2 is mainly described as a mitochondrial protein, a new nuclear function is emerging. Here, we observe that nuclear MTHFD2 protein levels and association with chromatin increase following ionizing radiation (IR) in an ataxia telangiectasia mutated (ATM)- and DNA-dependent protein kinase (DNA-PK)-dependent manner. Furthermore, repair of IR-induced DNA double-strand breaks (DSBs) is delayed upon MTHFD2 knockdown, suggesting a role for MTHFD2 in DSB repair. In support of this, we observe impaired recruitment of replication protein A (RPA), reduced resection, decreased IR-induced DNA repair protein RAD51 homolog 1 (RAD51) levels and impaired homologous recombination (HR) activity in MTHFD2-depleted cells following IR. In conclusion, we identify a key role for MTHFD2 in HR repair and describe an interdependency between MTHFD2 and HR proficiency that could potentially be exploited for Cancer therapy.

Keywords
DSB repair; MTHFD2; homologous recombination; ionizing radiation.
Products